Donald Klepser, PhD, MBA, professor and dean of academic affairs at the College of Pharmacy in the University of Nebraska Medical Center, discusses how the COVID-19 pandemic has changed the role of pharmacy technicians and what is expected as we move forward.
Utilizing Multidisciplinary and Patient-Centered Care to Manage Drug Toxicity
Susan Faye Dent, MD, FRCPC, FICQS, provides an overview of the BYLieve study and the impact on treatment options in patients with HR+, HER2- breast cancer.
Cultural competence should be thought in terms of being cognizant that there are differences in every single patient.
After noticing that there were few, if any, children’s books on the subject, Katrina Zearley wrote and published I Think When I Am Older I Might Be a Pharmacist!
CS Family Pharmacy has migrated to a combo-type pharmacy, integrating long term care.
Bunch Pharmacy has been in business for 24 years in the rural area of Alabama.
From the first approved CAR T therapy for multiple myeloma, to the recently-approved ciltacabtagene autoleucel, significant steps have been taken.
Vibhuti Arya Amirfar, PharmD, MPH, discusses building individual and systems resilience to dismantle structural racism in the pharmacy field.
Experts discuss tools and trainings that health care institutions have established during the pandemic to support hematology-oncology pharmacists who are struggling with wellness and mental health challenges.
Experts navigate MCL drug interactions, including those between BTK inhibitors with common anticoagulants and antifungals.
An intelligence-based system could help improve the timeliness of referrals to palliative care and hospice services in a community oncology environment.
Drs Jain and Wang discuss concerns regarding mutations in the treatment setting for patients with mantle cell lymphoma.
The American Diabetes Association guidelines have self-care and lifestyle recommendations for patients and health care professionals.
Learning the Pharmacists' Patient Care Process steps and being mindful or internalizing those can help set best practices for pharmacy team members.
James McCloskey, MD, analyzes result data from the QUAZAR AML-001 trial that focused on oral azacitidine.
Cole McCoy, PharmD, and Danielle Marcotulli, APN, RN, MSN, FNP-BC, AOCNP explain the additional agents being studied as maintenance therapy options.
Joe Duarte, co-founder and president of ContinuumMD, discusses a program model that allows pharmacies to provide virtual and in-person primary care options for rural communities with health care access challenges.
Christopher Fine, MD, FACC, a cardiologist at National Jewish Health, discusses how pharmacists can support patients with cancer who have a much higher risk of heart disease.
Lifestyle modifications are the cornerstone of treatment.
A lot of recent studies have focused on how to teach students and residents the Pharmacists' Patient Care Process (PPCP) and how pharmacists are already engaging with the PPCP.
These clear-cut guidelines help pharmacists making sure the patients are getting the right drug to set them up for success and prevent problems down the road.
Pharmacists are already doing a lot of things with the Pharmacists' Patient Care Process, but they haven't always used that language.
The future trend in managing diabetes will extend into glycemic control, weight reduction, and renal liver, for example.
The Pharmacist Patient Care Process provides really consistent language for pharmacists and pharmacy team members to talk about what teams are already doing.
David Pope, PharmD, CDE, the EVP of Innovation and Industry Relations at OmniSYS, discusses the FDA’s announcement updating pharmacists’ prescriptive authority for the COVID-19 antiviral Paxlovid.
By using technology solutions, pharmacists can be further integrated into the care team.
Christine Walko, PharmD, BCOP, FCCP, discusses some new developments for PARP inhibitors in cancer care for patients with homologous recombination deficiency.
Christopher Fine, MD, FACC, a cardiologist at National Jewish Health, discusses the relationship between heart disease and cancer and the importance of the field of cardio-oncology when treating patients with cancer.
In February of this year, the new statistics came out where we're at now 37 million with diabetes and 96 million with prediabetes.
